The Weekly Recap 10/04/24: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni receive regulatory clearance, secure new funding and contracts, enter strategic partnerships, appoint new executives, and much more on the road to LSI USA '25 in Dana Point, CA (March 17–21). This content is originally published here: https://www.lifesciencemarketr....esearch.com/insights

Insights from LSI USA '24: The Verticalization of AI in Medtech and Healthcare

The medtech market is experiencing a transformative shift with the integration of AI technologies in healthcare. At a panel at LSI USA '24, industry leaders discussed the rapid evolution of AI, its challenges, and the opportunities it brings. Here are six key points from the discussion, highlighting the implications for medical device investors and the broader healthcare industry. This blog is originally published here: https://www.lsiusasummit.com/n....ews/insights-from-ls

Insights from LSI USA ‘24: Stryker’s Journey to $20 Billion and the Role of M&A

Stryker’s long-term commitment to M&A has been a cornerstone of its growth strategy. Bryant Zanko, who leads corporate business development at Stryker, emphasized this commitment: “M&A has really been in our DNA. If you look at most of our divisions, the nucleus of that was an acquisition.” This long-term perspective has allowed Stryker to continually expand and innovate, leveraging acquisitions to build a robust portfolio across various healthcare segments. The focus on M&A strategy was driven by the recognition that acquisitions can be a powerful tool for achieving growth and maintaining a competitive edge in the medtech industry. For more information visit https://issuu.com/lsiusa25/doc....s/insights_from_lsi_